Products Exemestane is commercially available in the form of dragées and film-coated tablets (Aromasin, generics). It has been approved in many countries since 1999. Structure and properties Exemestane (C20H24O2, Mr = 296.4 g/mol), unlike other aromatase inhibitors, has a steroidal structure and resembles the natural substrate androstenedione. It exists as a white to slightly yellowish … Exemestane
Products Fulvestrant is commercially available as a solution for injection (Faslodex, generic). It has been approved in many countries since 2004. Structure and properties Fulvestrant (C32H47F5O3S, Mr = 606.8 g/mol) exists as a white powder that is practically insoluble in water. Effects Fulvestrant (ATC L02BA03) has antiestrogenic properties. It is an antagonist at the estrogen … Fulvestrant
Products In many countries, medroxyprogesterone acetate is commercially available in the form of an injection suspension as a three-month syringe (Depo-Provera, disposable syringes, D: Depo-Clinovir). Medroxyprogesterone acetate has been approved in many countries since 1964 and in the United States only since 1992. Structure and properties Medroxyprogesterone acetate (C24H34O4, Mr = 386.5 g/mol) is a … Three Month Injection
Products Aromatase inhibitors are commercially available in the form of film-coated tablets and coated tablets. The first third-generation agent to be approved in many countries was anastrozole in 1996 (Arimidex, USA 1995). Other drugs are available today. The active ingredients available today all belong to the third generation. Earlier agents such as aminoglutethimide and formestane … Aromatase Inhibitors
